Keyphrases
Indonesia
100%
COVID-19
62%
Tuberculosis
49%
Pediatric
40%
Pediatric COVID-19
32%
Jakarta
30%
Pneumonia
24%
Clinical Features
23%
Indonesian
23%
Clinical Manifestations
22%
Tuberculin Skin Test
22%
Nutritional Status
22%
Data Registry
21%
Safety Profile
21%
Post-COVID-19 Condition
21%
Tuberculosis Diagnosis
20%
Tuberculosis in children
17%
COVID-19 Pandemic
17%
COVID-19 in children
16%
Adverse Events Following Immunization
15%
Tuberculosis Infection
13%
Clinical Outcomes
13%
Healthy Adults
13%
Childhood Tuberculosis
13%
Children's Health
13%
Pediatric Sepsis
12%
TB Diagnosis
12%
Radiological Findings
12%
Fever
12%
Tertiary Referral Hospital
12%
Case Fatality Rate
12%
Multisystem Inflammatory Syndrome in children (MIS-C)
12%
Pulmonary Tuberculosis
11%
Pediatric Patients
11%
Incomplete Information
10%
Vasoactive-inotropic Score
10%
School Reopening
10%
Pediatric Septic Shock
10%
Substitution Therapy
10%
Randomised Controlled Trial Protocol
10%
Disseminated Tuberculosis
10%
Tuberculosis Spondylitis
10%
Plasminogen Activator inhibitor-1 (PAI-1)
10%
Lessons Learned
10%
Household Contacts
10%
Clinical Prognosis
10%
Tertiary Hospital
10%
Inactivated COVID-19 Vaccine
10%
HBsAg-positive Mothers
10%
Screening Process
10%
Medicine and Dentistry
COVID-19
95%
Pediatrics
81%
Mantoux Test
35%
Prevalence
25%
Polymerase Chain Reaction
21%
Nutritional Status
21%
Patient Referral
18%
Tuberculosis Diagnosis
18%
Mycobacterium Tuberculosis
14%
Serositis
12%
Septic Shock
12%
Sepsis
12%
Systematic Review
12%
Epileptic Seizure
12%
Cost-Effectiveness Analysis
10%
Latent Tuberculosis
10%
Health Care Cost
10%
Tuberculous Spondylitis
10%
Drug Resistant Epilepsy
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Postcovid Syndrome
10%
Miliary Tuberculosis
10%
Gastroesophageal Reflux
10%
Clinical Feature
10%
Retrospective Cohort Study
10%
Hemodialysis
10%
Pulmonary Hypertension
10%
Randomized Controlled Trial
10%
Substitution Therapy
10%
Drug Resistant Tuberculosis
10%
Inotropism
10%
Household
10%
End Stage Renal Disease
10%
Radiological Finding
10%
Radiology
10%
Childhood Tuberculosis
10%
Mixed Infection
10%
Interferon Gamma Release Assay
10%
Wassermann Test
10%
Human Immunodeficiency Virus
10%
Plasminogen Activator Inhibitor-1
10%
Lung
10%
Quality of Life
10%
Severe Acute Respiratory Syndrome
10%
Low and Middle Income Countries
10%
Post-COVID-19
10%
Diseases
10%
Fatality
9%
QuantiFERON
9%
Primary Health Care
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
33%
Clinical Feature
32%
Prevalence
28%
Tuberculin
28%
Coughing
22%
Adverse Event
21%
HIV
21%
Infection
21%
Coronavirinae
20%
Cross-Sectional Study
18%
Comorbidity
17%
Retrospective Study
15%
Midazolam
13%
Normal Human
13%
Inflammation
12%
COVID-19 Vaccine
10%
Abdominal Pain
10%
Case Fatality Rate
10%
Rhinorrhea
10%
Sepsis
10%
Down Syndrome
10%
Influenza Virus
10%
Chloramphenicol
10%
Ampicillin
10%
Plasminogen Activator Inhibitor 1
10%
Randomized Controlled Trial
10%
Latent Tuberculosis
10%
Gamma Interferon
10%
Base
10%
Flu Like Syndrome
10%
Respiratory Tract Disease
10%
Influenza A
10%
SARS Coronavirus
10%
Sinusitis
10%
Hepatitis B Antigen
10%
Miliary Tuberculosis
10%
Tuberculous Spondylitis
10%
Drug Resistant Epilepsy
10%
Hepatitis B Antibody
10%
Influenza B
10%
Headache
10%
Severe Acute Respiratory Syndrome
10%
Fatality
9%
Myalgia
7%
Mycobacterium Bovis BCG
7%
Mycobacterium Tuberculosis
7%
Ketorolac Trometamol
5%
Syndrome
5%
Respiratory Tract Infection
5%
Malaise
5%
